OR WAIT null SECS
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
The new line can fill prefilled syringes, cartridges, and vials using ready-to-use components.
Ajinomoto Bio-Pharma Services (Aji Bio-Pharma) announced on May 25, 2021 that it is installing a high speed, multi-purpose fill/finish line in its commercial manufacturing facility located in San Diego. The line will become fully operational in summer 2021.
The new line comes equipped with various configurations, including prefilled syringes, cartridges, and vials, while utilizing ready-to-use components that reduce preparation and packaging, Aji Bio-Pharma said in a company press release. Using SKAN isolated barrier technology to maintain the required sterility for fill/finish, the line can move 22,000 syringes per hour, with a batch capacity of over 200,000 syringes.
Additionally, along with the line, the fill suite will include two formulation suites, one of which is capable of handling flammable (class H) compounds.
"This expansion provides a significant increase in our current aseptic fill/finish capacity and allows for additional scheduling flexibility, as well as component flexibility," said Paul Ruther, director, Drug Product Manufacturing, Ajinomoto Bio-Pharma Services, in the press release. "Our continued investment in increasing capacity further enhances Aji Bio-Pharma's commitment in being a leading global and quality-driven [contract, development, and manufacturing organization] with comprehensive service offerings."
Source: Aji Bio-Pharma